Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-07-02, Stock:NVS, The news for the past five days is as follows:
2020-06-25: NEWS1: Novartis Settles DoJ and SEC Charges for $347 Million.NEWS2: Novartis, Units Admit Violating Bribery Law Bashed by Trump.NEWS3: UPDATE: Swiss drug company Novartis settles with DoJ, SEC in case brought under Foreign Corrupt Practices Act.NEWS4: Novartis, former unit to pay $346 million to resolve U.S. bribery charges.NEWS5: How to invest in health-care stocks without worrying about who wins the election.NEWS6: European stocks inch higher after previous day’s pounding; Wirecard collapses.
2020-06-26: NEWS1: EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Novartis AG – NVS.NEWS2: How gene therapy and CRISPR are helping to cure blindness.NEWS3: Novartis faces key meeting in U.S. bribery scandal after settling corruption case.NEWS4: ESG strategies still buoyant despite Covid, say in-house lawyers.
2020-06-29: NEWS1: Novartis Gets Positive CHMP View for Cosentyx Label Expansion.NEWS2: NVS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Novartis AG and Encourages Investors to Contact the Firm.NEWS3: Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed.NEWS4: These 6 health-care stocks are ‘buys’ because they can thrive under either Trump or Biden.NEWS5: Japan's Takeda expects $200 million operating loss related to Novartis' Xiidra withdrawal.
2020-06-30: NEWS1: NVS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Novartis AG and Encourages Investors to Contact the Firm.
2020-07-01: NEWS1: Novartis pays $729 million to settle U.S. kickback charges.NEWS2: Amgen's Win, Netflix's Hire Send Nasdaq Higher.NEWS3: Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise.

Answer: Decrease